Nuzenio

Investigational Obesity Drug

Investigational Obesity Drug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Neurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways. - PluangPluang · Fri, 07 Aug 2026 12:49:32 GMTLilly Expands Retatrutide Access Amid Doctor Pushback - The American Journal of Managed CareThe American Journal of Managed Care · Wed, 05 Aug 2026 20:37:18 GMTWho Is Eligible To Get Eli Lilly's Experimental Weight Loss Drug Before Approval? Criteria Explained - Health and MeHealth and Me · Wed, 05 Aug 2026 01:30:00 GMTA Next-Generation Obesity Drug Has Been Released By Eli Lilly in Early Access to Select Patients - Medical DailyMedical Daily · Tue, 04 Aug 2026 16:30:36 GMTIs 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test - MedPage TodayMedPage Today · Tue, 04 Aug 2026 13:43:14 GMTEli Lilly to offer early access to next-gen obesity drug to some patients - YahooYahoo · Mon, 03 Aug 2026 22:33:35 GMTWave Life Sciences: Obesity Drug Advances To Phase 2 With Potential For Fat Loss Without Muscle Loss - Pulse 2.0Pulse 2.0 · Sun, 02 Aug 2026 21:51:49 GMT

Timeline

Fri, 07 Aug 2026 12:49:32 GMTNeurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways. - Pluang
Wed, 05 Aug 2026 20:37:18 GMTLilly Expands Retatrutide Access Amid Doctor Pushback - The American Journal of Managed Care
Wed, 05 Aug 2026 01:30:00 GMTWho Is Eligible To Get Eli Lilly's Experimental Weight Loss Drug Before Approval? Criteria Explained - Health and Me
Tue, 04 Aug 2026 16:30:36 GMTA Next-Generation Obesity Drug Has Been Released By Eli Lilly in Early Access to Select Patients - Medical Daily
Tue, 04 Aug 2026 13:43:14 GMTIs 'Gym Penis' Real? Retatrutide Access Expanded; Vitamin D Fails Cancer Test - MedPage Today
Mon, 03 Aug 2026 22:33:35 GMTEli Lilly to offer early access to next-gen obesity drug to some patients - Yahoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Investigational Obesity Drug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.